Cargando…

Prevalence of Microvascular Complications in Newly Diagnosed Patients with Type 2 Diabetes

Background & Objective: Microvascular complications are the major outcome of type 2 Diabetes Mellitus progression, which reduce the quality of life, incur heavy economic burdens to the health care system and increase diabetic mortality. The aims of this study were to assess the prevalence of mic...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Alia, Iqbal, Farrukh, Taj, Azeem, Iqbal, Zafar, Amin, Muhammad Joher, Iqbal, Qasim Zafar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publicaitons 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817776/
https://www.ncbi.nlm.nih.gov/pubmed/24353655
_version_ 1782478127288549376
author Ali, Alia
Iqbal, Farrukh
Taj, Azeem
Iqbal, Zafar
Amin, Muhammad Joher
Iqbal, Qasim Zafar
author_facet Ali, Alia
Iqbal, Farrukh
Taj, Azeem
Iqbal, Zafar
Amin, Muhammad Joher
Iqbal, Qasim Zafar
author_sort Ali, Alia
collection PubMed
description Background & Objective: Microvascular complications are the major outcome of type 2 Diabetes Mellitus progression, which reduce the quality of life, incur heavy economic burdens to the health care system and increase diabetic mortality. The aims of this study were to assess the prevalence of microvascular complications among newly diagnosed type 2 diabetic patients and to analyze the association between these complications and poor glycemic control. Methods: This cross sectional hospital based study was carried out in Diabetic Clinic of Shaikh Zayed Postgraduate Medical Institute, Lahore Pakistan. The study was conducted from November 2011 to November 2012 among newly diagnosed type 2 diabetic patients. Relevant information of all patients was recorded with the help of a proforma. They were investigated for retinopathy, nephropathy and neuropathy. Results: We have divided the patients into two groups: Group I with good glycemic control (HbA(1)c <6.5) and group II with poor glycemic control (HbA(1)c >6.5). In group II microvascular complications were 89.8%. Neuropathy, nephropathy and retinopathy were present in 68.5%, 56.2% and 31.4% respectively. These similar percentages in Group I were 50%, 0% and 31% respectively and are significantly lower. Conclusion: The study showed that even in newly diagnosed type 2 diabetic patients who had poor glycemic control, frequency of microvascular complications is much higher as compared to those who had average glycemic control. Thus tight glycemic control does count even in newly diagnosed type 2 diabetics to prevent and minimize the occurrence of complications.
format Online
Article
Text
id pubmed-3817776
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Professional Medical Publicaitons
record_format MEDLINE/PubMed
spelling pubmed-38177762013-12-18 Prevalence of Microvascular Complications in Newly Diagnosed Patients with Type 2 Diabetes Ali, Alia Iqbal, Farrukh Taj, Azeem Iqbal, Zafar Amin, Muhammad Joher Iqbal, Qasim Zafar Pak J Med Sci Original Article Background & Objective: Microvascular complications are the major outcome of type 2 Diabetes Mellitus progression, which reduce the quality of life, incur heavy economic burdens to the health care system and increase diabetic mortality. The aims of this study were to assess the prevalence of microvascular complications among newly diagnosed type 2 diabetic patients and to analyze the association between these complications and poor glycemic control. Methods: This cross sectional hospital based study was carried out in Diabetic Clinic of Shaikh Zayed Postgraduate Medical Institute, Lahore Pakistan. The study was conducted from November 2011 to November 2012 among newly diagnosed type 2 diabetic patients. Relevant information of all patients was recorded with the help of a proforma. They were investigated for retinopathy, nephropathy and neuropathy. Results: We have divided the patients into two groups: Group I with good glycemic control (HbA(1)c <6.5) and group II with poor glycemic control (HbA(1)c >6.5). In group II microvascular complications were 89.8%. Neuropathy, nephropathy and retinopathy were present in 68.5%, 56.2% and 31.4% respectively. These similar percentages in Group I were 50%, 0% and 31% respectively and are significantly lower. Conclusion: The study showed that even in newly diagnosed type 2 diabetic patients who had poor glycemic control, frequency of microvascular complications is much higher as compared to those who had average glycemic control. Thus tight glycemic control does count even in newly diagnosed type 2 diabetics to prevent and minimize the occurrence of complications. Professional Medical Publicaitons 2013 /pmc/articles/PMC3817776/ /pubmed/24353655 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Ali, Alia
Iqbal, Farrukh
Taj, Azeem
Iqbal, Zafar
Amin, Muhammad Joher
Iqbal, Qasim Zafar
Prevalence of Microvascular Complications in Newly Diagnosed Patients with Type 2 Diabetes
title Prevalence of Microvascular Complications in Newly Diagnosed Patients with Type 2 Diabetes
title_full Prevalence of Microvascular Complications in Newly Diagnosed Patients with Type 2 Diabetes
title_fullStr Prevalence of Microvascular Complications in Newly Diagnosed Patients with Type 2 Diabetes
title_full_unstemmed Prevalence of Microvascular Complications in Newly Diagnosed Patients with Type 2 Diabetes
title_short Prevalence of Microvascular Complications in Newly Diagnosed Patients with Type 2 Diabetes
title_sort prevalence of microvascular complications in newly diagnosed patients with type 2 diabetes
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817776/
https://www.ncbi.nlm.nih.gov/pubmed/24353655
work_keys_str_mv AT alialia prevalenceofmicrovascularcomplicationsinnewlydiagnosedpatientswithtype2diabetes
AT iqbalfarrukh prevalenceofmicrovascularcomplicationsinnewlydiagnosedpatientswithtype2diabetes
AT tajazeem prevalenceofmicrovascularcomplicationsinnewlydiagnosedpatientswithtype2diabetes
AT iqbalzafar prevalenceofmicrovascularcomplicationsinnewlydiagnosedpatientswithtype2diabetes
AT aminmuhammadjoher prevalenceofmicrovascularcomplicationsinnewlydiagnosedpatientswithtype2diabetes
AT iqbalqasimzafar prevalenceofmicrovascularcomplicationsinnewlydiagnosedpatientswithtype2diabetes